Risk of invasive breast cancer in women diagnosed with ductal carcinoma in situ in Australia between 1995 and 2005This study provides the first Australian data on the risk of subsequent invasive breast cancer following a diagnosis of ductal carcinoma in situ. More Communicating a diagnosis of ductal carcinoma insitu (DCIS)NBOCC has developed a resource for clinicians to support discussions with women diagnosed with DCIS to improve their understanding about their diagnosis, prognosis, treatment and support.More Clinicians who work in breast or ovarian cancer we need your feedbackNBOCC is currently undertaking a program of evaluation. If you are a clinician who works in the area of breast and ovarian cancer, we invite you to undertake a short online survey, which should take no more than 10 minutes to complete. Thank you in advance for your input into this important work. |
Ovarian Cancer Awareness MonthOvarian Cancer Awareness Month is now officially the whole month of February. Anti-depressants and the effectiveness of tamoxifenOn 9 February, research published in the British Medical Journal examined the impact of a particular class of anti-depressants on the effectiveness of tamoxifen, prompting media coverage on the issue. |
9 February 2010 Australian-first study shows DCIS increases risk of invasive breast cancerWomen diagnosed with ductal carcinoma in situ (DCIS) are at significantly increased risk of being diagnosed with a subsequent invasive breast cancer according to study findings released today by the Australian Institute of Health and Welfare (AIHW) and National Breast and Ovarian Cancer Centre (NBOCC)read the release 24 February 2010 Despite improvements, prognosis still poor for women diagnosed with ovarian cancerDespite improvements in survival rates for ovarian cancer, the prognosis for women diagnosed with the disease remains relatively poor, according to the latest national report on ovarian cancer released today by the Australian Institute of Health and Welfare (AIHW) and National Breast and Ovarian Cancer Centre (NBOCC).read the release |
| More features | More news and events | More media releases |




















